Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2022-12-27 00:00:00 ET · period of report 2022-12-23 · accession 0001127602-22-028296 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-27 | 2022-12-23 | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $1.64 | -203.3K | 17.79M | -1% | -$333.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-12-23 | S | D | 203,349 | $1.64 | 17,787,655 | D | — | — |